Marwa Galal El-Gazzar | Computational drug design | Research Excellence Award

Posted on by Innovator Awards

Prof. Marwa Galal El-Gazzar | Computational drug design | Research Excellence Award

Egyptian Atomic Energy Authority | Egypt

Prof. Marwa Galal El-Gazzar is a distinguished scholar in pharmaceutical chemistry Computational drug design with extensive experience in radiation-based drug research and development. She is affiliated with the National Centre for Radiation Research and Technology under the Egyptian Atomic Energy Authority, where she has progressed through academic and research leadership roles to head the Drug Radiation Research Department. Her expertise centers on pharmaceutical analysis, radiation sterilization of pharmaceuticals, radiolytic stability studies, drug formulation, and quality control of irradiated medicinal products.Her research focuses on evaluating the impact of ionizing radiation on drug molecules, investigating degradation pathways, and developing validated analytical methods to ensure safety, efficacy, and regulatory compliance of pharmaceutical products. She has contributed to advancing the application of radiation technology in drug sterilization, polymeric biomaterials, and pharmaceutical packaging systems. In addition, her work supports the development of innovative formulations and stability-indicating methods using advanced spectroscopic and chromatographic techniques.Through sustained research output, supervision of postgraduate students, and collaboration within multidisciplinary teams, she has strengthened the integration of radiation science and pharmaceutical chemistry. Her contributions play a significant role in enhancing drug safety standards and promoting the peaceful applications of radiation technology in healthcare and pharmaceutical industries.

Citation Metrics (Google Scholar)

2000
1500
1000
500
0

Citations
1088

Documents
19

h-index
28

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications


Anti-inflammatory, analgesic and COX-2 inhibitory activity of novel thiadiazoles in irradiated rats

– Journal of Photochemistry and Photobiology B: Biology, 2017 (Citations: 59)

Mohammad Reza Mohammadi |  Infection Disease | Research Excellence Award

Posted on by Innovator Awards

Mr. Mohammad Reza Mohammadi |  Infection Disease | Research Excellence Award

Tarbiat Modares University | Iran 

He is a highly motivated researcher with advanced training in medical microbiology and a strong foundation in cellular and molecular biology. His academic background reflects a deep engagement with infectious disease research, particularly in the molecular detection and epidemiological investigation of clinically significant and neglected pathogens. His postgraduate research focused on the molecular identification of fastidious and unculturable bacterial agents associated with culture-negative endocarditis using advanced real-time polymerase chain reaction techniques, contributing valuable insights into diagnostic microbiology and clinical pathogen surveillance. His research expertise spans zoonotic diseases, molecular epidemiology, and neglected tropical diseases, with a strong emphasis on pathogen detection, diagnostic innovation, and molecular characterization. He demonstrates interdisciplinary competence across microbiology, molecular biology, and bioinformatics-supported meta-analysis approaches, enabling integrative research design and data interpretation. His work reflects a commitment to improving diagnostic accuracy, strengthening infectious disease surveillance systems, and advancing translational microbiological research. With a strong analytical mindset and research-driven approach, he shows high potential for impactful contributions in clinical microbiology, global health research, and molecular infectious disease science.

Citation Metrics (Google Scholar)

800
600
400
200
0

Citations
460

Documents
11

h-index
12

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications


Global prevalence and genetic diversity of Cryptosporidium spp. in pigeons: a systematic review and meta-analysis

F Mahdavi, M Mamizadeh, MR Mohammadi, A Pouryousef, G Sgroi, ...
Comparative Immunology, Microbiology and Infectious Diseases, Article 102437, 2025


Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

SB Sirota, RG Bender, RMV Dominguez, A Movo, LR Swetschinski, ...
The Lancet Infectious Diseases, 2025


Prevalence of Free-Living Amoebae in Various Water Sources in Iran: A Systematic Review and Meta-Analysis

L Shamsi, M Mamizadeh, MR Mohammadi, A Pouryousef, M Kheiry, ...
Acta Parasitologica 70(6): 220, 2025


Probiophage: A Novel Candidate for the Treatment of Irritable Bowel Disease (IBD): A Systematic Review

A Rahi, R Azizian, MR Mohammadi, N Namadiyam, A Azimi, M Hamidi
The Open Microbiology Journal 19(1), 2025

Xiaoou Sun | Cardiocerebrovascular Diseases | Research Excellence Award

Posted on by Innovator Awards

Dr. Xiaoou Sun | Cardiocerebrovascular Diseases | Research Excellence Award

Guangdong University of Technology | China

Xiaoou Sun is an accomplished academic researcher in the field of cell biology and biomedical sciences, with a strong background in genetics, Cardiocerebrovascular Diseases molecular biology, and translational research. His scholarly work focuses on understanding cellular and molecular mechanisms that regulate cell function, signal transduction, and disease progression, with particular relevance to human health and therapeutic development. Through his academic and research appointments at leading institutions in China and the United States, he has gained extensive experience in advanced experimental techniques, interdisciplinary collaboration, and independent research leadership. His research interests extend to biomedical and pharmaceutical sciences, including cellular regulation, disease-related molecular pathways, and the development of biologically informed strategies for drug discovery and biomedical innovation. In addition to research, he is actively involved in teaching and mentoring, contributing to the training of students in bioscience and bioengineering disciplines. His academic contributions reflect a commitment to integrating fundamental cell biology with applied biomedical research, supporting innovation in pharmaceutical science and translational medicine. Through sustained research activity and academic service, he continues to advance scientific understanding while fostering interdisciplinary approaches that bridge basic biological research and real-world biomedical applications.

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
1182

Documents
43

h-index
21

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Posted on by Innovator Awards

Dr. Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Shiraz University| Iran

Mohammad Sadegh Taghizadeh is based at the Agricultural Faculty of Shiraz University (Institute of Biotechnology, Shiraz-Isfahan Highway, Shiraz, Iran) where he pursues advanced research in bioactive small molecules and peptides—whether synthesised by ribosomes or derived from proteins. His work spans in vitro isolation, purification and structural-physicochemical characterisation of these compounds, their pharmacological and sensory properties, and complementary in silico design and target-interaction studies. He also explores recombinant production of bioactive peptides using plant and bacterial expression systems. Prior to his current role, he earned a bachelor’s in agricultural engineering (plant protection) at Shahid Bahonar University of Kerman, a master’s in plant biotechnology at University of Guilan (thesis: factors affecting virulence genes of Agrobacterium tumefaciens in Arabidopsis thaliana mutants), and a PhD in biotechnology at Shiraz University (dissertation: functional properties of bio-active peptides derived from plant resources). He gained research experience at the Medical University of Vienna (on discovery of a novel cyclotide targeting the CCK2 receptor) and later led a project on plant-derived bioinsecticides funded by the National Elite Foundation of Iran, while also teaching as a TA in plant genetic engineering, molecular markers and plant tissue culture at Shiraz University. His research has steadily contributed to the field of peptide biotechnology, with growing recognition: his h-index currently stands at (unknown) and his publication and citation counts are steadily rising as he continues to establish himself in the realm of bioactive small molecules and recombinant peptide production.

Profile: Orcid  |  Scopus 

Featured Publications 

Abbasi, A., Taghizadeh, M. S., Moghadam, A., Niazi, A., Lotfi, M., & Taghavi, S.-M. (2025). A comprehensive insight into ultrasound-assisted protein extraction from Camelina sativa and de-bittering of resulting hydrolysates with emphasis on their structural, physicochemical, sensory, and biological properties. Food Chemistry, 445, 145435.

Taghizadeh, M. S., Niazi, A., Mirzapour-Kouhdasht, A., Pereira, E. C., & Garcia-Vaquero, M. (2025). Enhancing cyclotide bioproduction: Harnessing biological synthesis methods and various expression systems for large-scale manufacturing. Critical Reviews in Biotechnology, 45(1), 1–20.

Hoseini, S., Moghadam, A., Palizban, A., Hoseini, F., Taghizadeh, M. S., Choopani, A., & Hoseini, F. (2025). Immune boosting by pharmaceutical C-phycocyanin, in vitro and in silico effects on peripheral blood mononuclear cells. Health Biotechnology and Biopharma, 8(1), 1–10.

Lotfi, M., Keshvari, T., Taghizadeh, M. S., Afsharifar, A., Moghadam, A., Aram, F., & Niazi, A. (2025). Optimizing Camelina sativa oil extraction and its cytotoxicity using RSM by emphasis on antioxidant properties, physical characteristics, and molecular docking insights. Industrial Crops and Products, 215, 120334.

Taghizadeh, M. S., Mirzapour-Kouhdasht, A., & Huang, J.-Y. (2025, December). Unraveling the structure-activity relationship and molecular mechanisms for targeted therapeutic applications of food-derived angiotensin-I-converting enzyme inhibitory peptides. Food Bioscience, 65, 107820.

Prof. Adriana  Montaño – Lysosomal storage disorders & Brain – Best Researcher Award

Posted on by Innovator Awards

Prof. Adriana  Montaño - Lysosomal storage disorders & Brain - Best Researcher Award

Saint Louis University - United States

Author Profile 

ORCID 

🎓 Early academic pursuits

Adriana Maria Montaño Suárez embarked on her academic journey with a passion for biological sciences, earning her Bachelor of Science in Biology from the University of Los Andes, Bogotá, Colombia. Her early interest in biochemistry led her to work as a research assistant at the Biochemistry Research Center in Colombia. Seeking to expand her expertise, she pursued her Ph.D. in Medical Sciences at Gifu University in Japan, where she focused on the genetic and biochemical aspects of metabolic disorders. Her dissertation on the mouse N-acetylgalactosamine-6-sulfate sulfatase (Galns) gene showcased her dedication to understanding genetic regulation and metabolic pathways. Additionally, she honed her linguistic skills by completing a Japanese language course at Nagoya University, which facilitated her research and integration into Japan's scientific community.

🌟 Professional endeavors

Dr. Montaño Suárez's career has been marked by significant roles in academia and research. After completing her postdoctoral training at prestigious institutions in the USA and Japan, she joined the School of Medicine at Saint Louis University as an assistant professor in the Department of Pediatrics. Over the years, she progressed through the ranks, earning tenure and becoming a professor in both the Department of Pediatrics and the Department of Biochemistry and Molecular Biology. Her leadership abilities were recognized, leading her to serve as Vice Dean for Research at the School of Medicine and later as the Interim Senior Associate Dean for Research. In 2024, she was honored with the Dr. Robert Wilmott IMMUNO Chair in Pediatric Research, solidifying her influence in pediatric medicine and molecular biology.

🤝 Contributions and research focus

A pioneer in molecular biology and pediatrics, Dr. Montaño Suárez's research primarily focuses on inborn errors of metabolism and lysosomal storage disorders. Her work has significantly contributed to understanding the molecular mechanisms underlying mucopolysaccharidoses (MPS), a group of rare genetic diseases affecting lysosomal function. Her studies have paved the Lysosomal storage disorders & Brain way for gene therapy and enzyme replacement strategies, offering new hope for patients suffering from these debilitating disorders. Through her extensive research in biochemical  genetics and molecular pathways, she has contributed to the development of potential therapeutic interventions, making a lasting impact on metabolic disorder treatments.

🏆 Accolades and recognition

Dr. Montaño Suárez's dedication and contributions to science have been recognized globally. She is a member of the National Academy of Inventors (NAI), reflecting her innovative Lysosomal storage disorders & Brain approach to research and biotechnology. She is also an esteemed member of various international and national societies, including the Society for the Study of Inborn Errors of Metabolism (SSIEM), the American Society of Human Genetics (ASHG), and the American Society of Gene and Cell Therapy (ASGCT). Her groundbreaking work has earned her multiple grants and awards, reinforcing her reputation as a leading researcher in her field.

📚 Impact and influence

Beyond her scientific contributions, Dr. Montaño Suárez has been a mentor and role model for young researchers and students. Her involvement in teaching, research mentoring, and academic leadership has shaped the careers of numerous scientists in molecular biology and pediatric research. As an advocate for interdisciplinary collaboration, she has fostered Lysosomal storage disorders & Brain partnerships between biochemists, geneticists, and pediatricians to advance precision medicine and genetic therapies. Her influence extends beyond the laboratory, as she actively participates in global discussions on rare diseases and genetic research, driving policy changes and awareness initiatives.

🌍 Legacy and future contributions

Dr. Montaño Suárez's legacy lies in her unwavering commitment to medical genetics and pediatric research. Her efforts in gene therapy and molecular diagnostics continue to inspire the next generation of scientists. As she holds prestigious academic and research leadership positions, her future contributions are expected to shape the evolution of personalized medicine and advanced therapeutic approaches for metabolic diseases. Through her research, mentorship, and leadership, she is paving the way for breakthroughs in genetic medicine that will benefit countless patients worldwide.

Notable Publications 

  • Title: Hydrogel Delivery Device for the In Vitro and In Vivo Sustained Release of Active rhGALNS Enzyme
    Author(s): Flanagan M, Gan Q, Sheth S, Schafer R, Ruesing S, Winter LE, Toth K, Silviya Zustiak, Montaño AM
    Journal: Pharmaceuticals (Basel, Switzerland), 2023

  • Title: Growth Patterns in Patients with Mucopolysaccharidosis VII
    Author(s): Montaño AM, Różdżyńska-Świątkowska A, Jurecka A, Ramirez AN, Zhang L, Marsden D, Wang RY, Paul Harmatz
    Journal: Molecular Genetics and Metabolism Reports, 2023

  • Title: DLX6 and MSX1 from Saliva Samples as Potential Predictors of Mandibular Size: A Cross-Sectional Study
    Author(s): Cooper RBV, Kim KB, Oliver DR, Armbrecht E, Behrents RG, Montaño AM
    Journal: American Journal of Orthodontics and Dentofacial Orthopedics, 2022

  • Title: Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease
    Author(s): Montavon B, Winter LE, Gan Q, Arasteh A, Montaño AM
    Journal: Frontiers in Cardiovascular Medicine, 2022

  • Title: Epidemiology of Mucopolysaccharidoses (MPS) in United States: Challenges and Opportunities
    Author(s): Puckett Y, Mallorga-Hernández A, Adriana M. Montaño
    Journal: Orphanet Journal of Rare Diseases, 2021